Jeena Sikho Lifecare Shares Jump 14% After Announcing Strong Q3 Results; Check Details
Synopsis: Healthcare stock jumps 14% as Q3 profit soars 405 % YoY, driven by strong revenue growth, margin expansion, and robust performance across Ayurveda services and products businesses. The shares of this company, which operates under brands like Shuddhi Ayurveda (products), Shuddhi Clinics, and HIIMS (Hospital & Institute of Integrated Medical Sciences), are in focus […] The post Jeena Sikho Lifecare Shares Jump 14% After Announcing Strong Q3 Results; Check Details appeared first on Trade Brains.
Synopsis: Healthcare stock jumps 14% as Q3 profit soars 405 % YoY, driven by strong revenue growth, margin expansion, and robust performance across Ayurveda services and products businesses.
The shares of this company, which operates under brands like Shuddhi Ayurveda (products), Shuddhi Clinics, and HIIMS (Hospital & Institute of Integrated Medical Sciences), are in focus after strong Q3 results.
With a market capitalization of Rs 9,840 crore, Jeena Sikho Lifecare Ltd’s shares on Monday made a day high of Rs 809.45 per share, up by 13.85 percent from its previous day’s close price of Rs 710.95 per share. The share of this company has given a return of 4,122 percent since its listing in May 2022.
Results Highlights
- QoQ View: The revenue from operations grew by 16.8 percent to Rs 222 crore in Q3 FY26 from Rs 190 crore in Q2 FY26. EBDIT grew by 9.7 percent to Rs 101 crore in Q3 FY26 from Rs 92 crore in Q2 FY26. Accompanied by a net profit growth 13.2 percent to Rs 66.6 crore from Rs 58.8 crore, resulting in an EPS of Rs 5.36 per share from Rs 4.73 per share in the last quarter.
- YoY View: The revenue from operations grew by 92 percent to Rs 222 crore in Q3 FY26 from Rs 116 crore in Q3 FY25. EBDIT grew by 240 percent to Rs 101 crore in Q3 FY26 from Rs 29.6 crore in Q3 FY25. Accompanied by a net profit growth of 405 percent to Rs 66.6 crore in Q3 FY26 from Rs 13.2 crore in Q3 FY25, resulting in an EPS growth of 406 percent to Rs 5.36 per share in Q3 FY26
In Q3FY26, operating metrics reflected healthy volume-led growth across segments, with OPD volumes rising 89 percent YoY and IPD volumes increasing 84 percent, indicating sustained patient traction. Day care volumes grew 139 percent, and Video-call consultancy grew 214 percent YoY, while OPD, COD & VC patient volumes surged 247 percent YoY, highlighting strong momentum in higher-value treatments and integrated care services.
The company follows a differentiated Ayurveda-led business model with a balanced mix of health care services and products. The services segment operates through a hub-and-spoke network of hospitals and clinics, maintaining a CAPEX- and OPEX-light structure with strong operating leverage beyond break-even occupancy. This vertical generated Rs 288 crore revenue in 9MFY26, contributing 49 percent to overall revenues.
The products segment leverages healthcare centres, tele-calling, and e-commerce channels, supported by outsourced manufacturing and a portfolio delivering around 85 percent gross margins. It reported Rs 298 crore in revenue in 9MFY26, accounting for a 51 percent contribution, while strong cross-selling ensures that medicine customers transition to centres and that patients continue product consumption post-treatment.
About the company
Established in 2009, Jeena Sikho Lifecare Limited (JSLL) is a leading Indian Ayurvedic healthcare company that offers a wide range of services from herbal products to full-fledged hospitals, aiming to make Ayurveda accessible, effective, and relevant for modern health challenges, treating conditions like diabetes, cancer, and kidney/liver issues.
The company has a strong healthcare presence across Uttar Pradesh, Punjab, Maharashtra, and Haryana, complemented by a diversified product portfolio spanning Ayurvedic formulations and over-the-counter products, catering to both therapeutic and preventive health needs across multiple consumer segments.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Jeena Sikho Lifecare Shares Jump 14% After Announcing Strong Q3 Results; Check Details appeared first on Trade Brains.
What's Your Reaction?

